Nowy Swiat 72
Warsaw, 00-330
Poland
The Institute of Law Studies at the Polish Academy of Sciences
Intellectual property, regulatory test data, clinical trial data, pharmaceutical products, confidentiality, human rights, Charter of Fundamental Rights of the European Union, European Medicines Agency
regulatory protection, data exclusivity, market exclusivity, reference medicinal products, orphan drugs, pharmaceutical reform
innovation, health industry, polish health sector, R&D
innovation, intellectual property, patents, pharmaceuticals, medical technology
